Stock Research for MYGN

MYGN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

MYGN Stock Chart & Research Data

The MYGN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MYGN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


MYGN Due diligence Resources & Stock Charts

The MYGN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MYGN Detailed Price Forecast - CNN Money CNN View MYGN Detailed Summary - Google Finance
Yahoo View MYGN Detailed Summary - Yahoo! Finance Zacks View MYGN Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View MYGN Trends & Analysis - Trade-Ideas Barrons View MYGN Major Holders - Barrons
NASDAQ View MYGN Call Transcripts - NASDAQ Seeking View MYGN Breaking News & Analysis - Seeking Alpha
Spotlight View MYGN Annual Report - CompanySpotlight.com OTC Report View MYGN OTC Short Report - OTCShortReport.com
TradeKing View MYGN Fundamentals - TradeKing Charts View MYGN SEC Filings - Bar Chart
WSJ View Historical Prices for MYGN - The WSJ Morningstar View Performance/Total Return for MYGN - Morningstar
MarketWatch View the Analyst Estimates for MYGN - MarketWatch CNBC View the Earnings History for MYGN - CNBC
StockMarketWatch View the MYGN Earnings - StockMarketWatch MacroAxis View MYGN Buy or Sell Recommendations - MacroAxis
Bullish View the MYGN Bullish Patterns - American Bulls Short Pains View MYGN Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View MYGN Stock Mentions - StockTwits PennyStocks View MYGN Stock Mentions - PennyStockTweets
Twitter View MYGN Stock Mentions - Twitter Invest Hub View MYGN Investment Forum News - Investor Hub
Yahoo View MYGN Stock Mentions - Yahoo! Message Board Seeking Alpha View MYGN Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for MYGN - SECform4.com Insider Cow View Insider Transactions for MYGN - Insider Cow
CNBC View MYGN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MYGN - OTC Markets
Yahoo View Insider Transactions for MYGN - Yahoo! Finance NASDAQ View Institutional Holdings for MYGN - NASDAQ


Stock Charts

FinViz View MYGN Stock Insight & Charts - FinViz.com StockCharts View MYGN Investment Charts - StockCharts.com
BarChart View MYGN Stock Overview & Charts - BarChart Trading View View MYGN User Generated Charts - Trading View




Latest Financial News for MYGN


Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know
Posted on Wednesday April 24, 2024

Myriad (MYGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.


Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor
Posted on Wednesday April 17, 2024

80% of people diagnosed with anxiety, depression report losing years or decades of timeSALT LAKE CITY, April 17, 2024 (GLOBE NEWSWIRE) -- An astonishing 44% of Americans feel they have lost time in their lives due to poor mental health. That number jumps to nearly 80% for those diagnosed with anxiety and/or depression, according to the latest GeneSight Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine. Of those


New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
Posted on Tuesday April 16, 2024

SALT LAKE CITY, April 16, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that Prenatal Diagnosis has published a study1 demonstrating exceptional positive predictive value (PPV) for 22q11.2 microdeletion screening using Myriad’s prenatal cell-free DNA (pcfDNA) screen, Prequel®, which incorporates fetal fraction amplification. Prior studies from other commercial pcfDNA laboratories have reported a broad range of


Myriad Genetics (MYGN) Announces Favorable Research Results
Posted on Thursday April 11, 2024

Myriad Genetics' (MYGN) latest positive initial study outcome is likely to improve clinical outcomes and reduce overall healthcare costs.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.